Literature DB >> 2401299

Mitosis-specific histone H3 phosphorylation in vitro in nucleosome structures.

K Shibata1, M Inagaki, K Ajiro.   

Abstract

A mechanism of mitosis-specific enhancement of histone H3 phosphorylation was analyzed in vitro in terms of nucleosome structure. The incorporation of [32P]phosphate into DNA-bound H3 was approximately 5-7 times higher than in DNA-free H3 using the catalytic subunit of cAMP-dependent protein kinase. The two major N-terminal serine sites, including the mitosis-specific site (Ser10) and Ser28, were extensively phosphorylated in the DNA-bound forms. These phosphorylation patterns were identical to those of nucleosomal H3. In contrast, the H3 in DNA-free octamers was very slightly phosphorylated. The major site of H3 phosphorylation in DNA-free H3 was Thr118 in the C-terminus. Results indicate that DNA-binding is essential for the high level of mitosis-specific H3 phosphorylation, and that the nucleosome structure promotes H3 N-terminal phosphorylation in vitro. It also suggests the possibility that H1 prevents H3 phosphorylation during interphase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401299     DOI: 10.1111/j.1432-1033.1990.tb19199.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  23 in total

1.  Disappearance of the negative charge in giant DNA with a folding transition.

Authors:  Y Yamasaki; Y Teramoto; K Yoshikawa
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

2.  Embryonic multipotent progenitors remodel the Drosophila airways during metamorphosis.

Authors:  Chrysoula Pitsouli; Norbert Perrimon
Journal:  Development       Date:  2010-11       Impact factor: 6.868

3.  SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.

Authors:  Nathalie Cohet; Kathleen M Stewart; Rajini Mudhasani; Ananthi J Asirvatham; Chandrashekara Mallappa; Karen M Imbalzano; Valerie M Weaver; Anthony N Imbalzano; Jeffrey A Nickerson
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

4.  Exit from mitosis in Drosophila syncytial embryos requires proteolysis and cyclin degradation, and is associated with localized dephosphorylation.

Authors:  T T Su; F Sprenger; P J DiGregorio; S D Campbell; P H O'Farrell
Journal:  Genes Dev       Date:  1998-05-15       Impact factor: 11.361

5.  Dietary docosahexaenoic acid supplementation modulates hippocampal development in the Pemt-/- mouse.

Authors:  Kerry-Ann da Costa; Kiranmai S Rai; Corneliu N Craciunescu; Komal Parikh; Mihai G Mehedint; Lisa M Sanders; Audrey McLean-Pottinger; Steven H Zeisel
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

6.  FGF controls epithelial-mesenchymal transitions during gastrulation by regulating cell division and apicobasal polarity.

Authors:  Jingjing Sun; Angelike Stathopoulos
Journal:  Development       Date:  2018-10-01       Impact factor: 6.868

7.  Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction.

Authors:  M J Barratt; C A Hazzalin; E Cano; L C Mahadevan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Histone H3 Ser10 phosphorylation-independent function of Snf1 and Reg1 proteins rescues a gcn5- mutant in HIS3 expression.

Authors:  Yang Liu; Xinjing Xu; Soumya Singh-Rodriguez; Yan Zhao; Min-Hao Kuo
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

9.  Prognostic significance of phospho-histone H3 in prostate carcinoma.

Authors:  Michael Nowak; Maria A Svensson; Jessica Carlsson; Wenzel Vogel; Moritz Kebschull; Nicolas Wernert; Glen Kristiansen; Ove Andrén; Martin Braun; Sven Perner
Journal:  World J Urol       Date:  2013-07-26       Impact factor: 4.226

10.  The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest.

Authors:  Keiko Sakai; Joseph Dimas; Michael J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.